Qiaonan Shan

1.0k total citations
16 papers, 547 citations indexed

About

Qiaonan Shan is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Qiaonan Shan has authored 16 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Surgery. Recurrent topics in Qiaonan Shan's work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Cancer Mechanisms and Therapy (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Qiaonan Shan is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Cancer Mechanisms and Therapy (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Qiaonan Shan collaborates with scholars based in China, Canada and Madagascar. Qiaonan Shan's co-authors include Shusen Zheng, Xiao Xu, Haiyang Xie, Haojiang Dai, Sunbin Ling, Penghong Song, Xuyong Wei, Lin Zhou, Zhikun Liu and Jimin Liu and has published in prestigious journals such as Advanced Science, Cell Death and Disease and Journal of Hematology & Oncology.

In The Last Decade

Qiaonan Shan

16 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiaonan Shan China 12 305 173 101 83 73 16 547
Ester Gonzalez‐Sanchez Spain 15 249 0.8× 185 1.1× 90 0.9× 132 1.6× 105 1.4× 25 605
Liangcai Wu China 15 277 0.9× 166 1.0× 200 2.0× 89 1.1× 90 1.2× 24 635
Manar Atyah China 13 287 0.9× 135 0.8× 204 2.0× 42 0.5× 53 0.7× 27 543
Aitor Benedicto Spain 13 206 0.7× 183 1.1× 89 0.9× 98 1.2× 54 0.7× 26 579
Liuxin Cai China 10 381 1.2× 208 1.2× 205 2.0× 55 0.7× 146 2.0× 18 712
Heping Yang China 10 236 0.8× 98 0.6× 114 1.1× 58 0.7× 95 1.3× 24 499
Guandou Yuan China 17 343 1.1× 114 0.7× 213 2.1× 163 2.0× 62 0.8× 55 698

Countries citing papers authored by Qiaonan Shan

Since Specialization
Citations

This map shows the geographic impact of Qiaonan Shan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiaonan Shan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiaonan Shan more than expected).

Fields of papers citing papers by Qiaonan Shan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiaonan Shan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiaonan Shan. The network helps show where Qiaonan Shan may publish in the future.

Co-authorship network of co-authors of Qiaonan Shan

This figure shows the co-authorship network connecting the top 25 collaborators of Qiaonan Shan. A scholar is included among the top collaborators of Qiaonan Shan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiaonan Shan. Qiaonan Shan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Chen, Ronggao, Xin‐Hua Hu, Yao Jiang, et al.. (2025). Regulated Cell Death in Lenvatinib Resistance of Hepatocellular Carcinoma: from Molecular Mechanisms to Therapeutic Strategies. International Journal of Biological Sciences. 21(5). 2012–2026. 3 indexed citations
2.
Feng, Zijie, Xin He, Xuyao Zhang, et al.. (2022). Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissues. Nature Cancer. 3(5). 581–594. 69 indexed citations
3.
4.
Ye, Qianwei, Sunbin Ling, Guangjiang Jiang, et al.. (2021). Sirolimus-based immunosuppression improves the prognosis of liver Transplantation Recipients with low TSC1/2 expression in hepatocellular carcinoma beyond the Milan Criteria. European Journal of Surgical Oncology. 47(10). 2533–2542. 11 indexed citations
5.
Xu, Shengjun, Sunbin Ling, Qiaonan Shan, et al.. (2021). Self‐Activated Cascade‐Responsive Sorafenib and USP22 shRNA Co‐Delivery System for Synergetic Hepatocellular Carcinoma Therapy. Advanced Science. 8(5). 2003042–2003042. 49 indexed citations
6.
Ling, Sunbin, Tingting Feng, Qifan Zhan, et al.. (2020). Sirolimus-based immunosuppression improves outcomes in liver transplantation recipients with hepatocellular carcinoma beyond the Hangzhou criteria. Annals of Translational Medicine. 8(4). 80–80. 11 indexed citations
7.
Zhan, Qifan, Sunbin Ling, Yinan Deng, et al.. (2020). Hangzhou criteria as downstaging criteria in hepatocellular carcinoma before liver transplantation: A multicenter study from China. Hepatobiliary & pancreatic diseases international. 19(4). 349–357. 18 indexed citations
8.
Wen, Xue, Sunbin Ling, Qiaonan Shan, et al.. (2019). Ubiquitin-Specific Protease 22/Silent Information Regulator 1 Axis Plays a Pivotal Role in the Prognosis and 5-Fluorouracil Resistance in Hepatocellular Carcinoma. Digestive Diseases and Sciences. 65(4). 1064–1073. 16 indexed citations
9.
Liu, Zhikun, Jie Li, Jun Chen, et al.. (2018). MCM family in HCC: MCM6 indicates adverse tumor features and poor outcomes and promotes S/G2 cell cycle progression. BMC Cancer. 18(1). 200–200. 99 indexed citations
10.
Ling, Sunbin, Jie Li, Qiaonan Shan, et al.. (2017). USP22 mediates the multidrug resistance of hepatocellular carcinoma via the SIRT1/AKT/MRP1 signaling pathway. Molecular Oncology. 11(6). 682–695. 84 indexed citations
11.
Ling, Sunbin, Qiaonan Shan, Peng Liu, et al.. (2017). Metformin ameliorates arsenic trioxide hepatotoxicity via inhibiting mitochondrial complex I. Cell Death and Disease. 8(11). e3159–e3159. 51 indexed citations
12.
Ling, Sunbin, Haiyang Xie, Fan Yang, et al.. (2017). Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1. Journal of Hematology & Oncology. 10(1). 59–59. 61 indexed citations
13.
Gao, Feng, Qiaonan Shan, Qi Ling, et al.. (2016). Predictive value of tumor markers in patients with recurrent hepatocellular carcinoma in different vascular invasion pattern. Hepatobiliary & pancreatic diseases international. 15(4). 371–377. 20 indexed citations
14.
Liu, Yu-Hui, Xuyong Wei, Kun Wang, et al.. (2016). Enucleation versus Anatomic Resection for Giant Hepatic Hemangioma: A Meta-Analysis. PubMed. 3(3-4). 153–162. 19 indexed citations
15.
Liu, Zhikun, Haijun Guo, Feng Gao, et al.. (2016). Fibrinogen and D‐dimer levels elevate in advanced hepatocellular carcinoma: High pretreatment fibrinogen levels predict poor outcomes. Hepatology Research. 47(11). 1108–1117. 25 indexed citations
16.
Li, Zhenli, Dan Yu, Meifu Gan, et al.. (2015). A genome-wide assessment of rare copy number variants in colorectal cancer. Oncotarget. 6(28). 26411–26423. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ester Gonzalez‐Sanchez Breakdown of academic impact, for papers by Liangcai Wu Breakdown of academic impact, for papers by Manar Atyah Breakdown of academic impact, for papers by Aitor Benedicto Breakdown of academic impact, for papers by Liuxin Cai Breakdown of academic impact, for papers by Heping Yang Breakdown of academic impact, for papers by Guandou Yuan
Rankless by CCL
2026